Figure 2 Giant-Cell Tumor of the Lower Portion of the Right ... A plaster cast was applied in an attempt to obtain normal position of the hand. The pathological report was as follows: On ...

Romvimza is a medicine called a kinase inhibitor that is used to treat tenosynovial giant cell tumor (TGCT) that may be made worse by surgery. TGCT is a condition where tumors form in joints of ...

Emactuzumab, a humanized immunoglobulin G1 monoclonal antibody, targets the CSF-1 receptor and inhibits macrophages in tumor tissue.

In April, a hand tumor specialist recommend she underwent ... The results confirmed it was a benign tumor, but it was an aggressive type of giant cell tumor, so doctors removed it during surgery ...

Emactuzumab demonstrated a 71% objective response rate, rapid tumor reduction, and manageable side effects in early trials. Emactuzumab has received fast track designation from the U.S. FDA for ...

Prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors Treatment of adults and skeletally mature adolescents with giant cell ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition ...